Anti-inflammation compounds
US9029389B2 · kind B2 · utility
26Cited by
0References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 20, 2012 |
| Grant date | May 12, 2015 |
| Priority date | — |
| Expiry date | Apr 20, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention refers to: a compound having the general formula (I), wherein n is 0, 1, 2 or; m is 0, 1, 2 or 3; o is 0, 1, 2 or 3; W, X, Y and Z are independently selected from CH, N or N-oxide; A is NR4, C═O, C═S, OP(O)(O), P═O, CH2, or a heteroarly selected from the group consisting of (a), (b), (c), (d), (e), (f), (g); V is C═O, O, S, CH2, or NR5; as well as its use in treating inflammatory diseases such as asthma, COPD, inflammation post infection, arthritis, atherosclerosis, pain and dermatitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.